Skip to main content
VulnerabilityPublished Updated

CVE-2025-57881: MedDream PACS Premium · Cross-site Scripting

Affects MedDream PACS PremiumSource CVE Database V5

0

Not known to be exploited · CVSS 6.1 Medium.

Data as of 26 Oct 2026, 14:05 UTC

CVSS 3.1 base score
6.1Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 29% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 20 Jan 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
MedDreamMedDream PACS PremiumAffected
  • =7.3.6.870
Fixed in–

AI-suggested

  1. Immediate mitigation should include educating users, especially healthcare staff, about the risks of clicking on unsolicited or suspicious links, emphasizing phishing awareness.
  2. Deploy web application firewalls (WAFs) with rules specifically designed to detect and block reflected XSS payloads targeting the modifyEmail functionality.
  3. Implement strict input validation and output encoding on all user-supplied inputs within the application, particularly in the modifyEmail feature, to neutralize malicious scripts.
  4. 5. Monitor web server and application logs for unusual URL patterns or repeated access attempts to the vulnerable endpoint. 6. Consider isolating or restricting access to the PACS web interface to trusted networks or VPNs to reduce exposure. 7. Conduct regular security assessments and penetration testing focused on web application vulnerabilities to detect similar issues proactively.

Description

CVE-2025-57881 is a reflected cross-site scripting (XSS) vulnerability in MedDream PACS Premium version 7.3.6.870, specifically in the modifyEmail functionality. An attacker can craft a malicious URL that, when visited by a user, executes arbitrary JavaScript code in the context of the victim's browser. This vulnerability requires user interaction (clicking the malicious link) but does not require authentication. The vulnerability impacts confidentiality and integrity by potentially allowing session hijacking, credential theft, or unauthorized actions within the application. The CVSS score is 6.1 (medium severity), reflecting the network attack vector, low attack complexity, no privileges required, but user interaction needed. No known exploits are currently reported in the wild.

References

Community reviews

Loading reviews…